MedTrace Logo

Reaching in Stroke

NCT02654951 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2017-04-04

No results posted yet for this study

Summary

The project targets stroke survivors to investigate the effect of augmented feedback (using robotic force cues and visual feedback) on their upper limb reaching patterns and trunk compensatory movements.

Conditions

Interventions

OTHER

Visual Feedback

The visual feedback condition will use a monitor to display two cursors (empty circles) that will represent the participant's hands, and the circles will fill with red ink as the user starts to compensate outside a "normal" error band. The amount of red ink will increase proportionally to the magnitude of trunk compensation. The goal of the participants will be to move their hands/cursors towards a target, while keeping the cursors as empty as possible.

OTHER

Force Feedback

A monitor will display the same cursors as in the visual feedback condition, however, the cursors will be completely empty and will not fill with color. The force feedback cues will be provided as resistance to move the robots' handles. These cues will be applied when the user moves outside a "normal" error band. In addition, the magnitude of the cue will be proportional to the magnitude of trunk compensation. The goal of the participants will be to move their hands/cursors towards a target, while moving the robots with the least resistance possible.

Sponsors & Collaborators

  • UBC Peter Wall Institute for Advanced Studies

    collaborator UNKNOWN

  • National Council of Science and Technology, Mexico

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Machiel Van Der Loos, PhD · The University of British Columbia- Associate Professor

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02654951 on ClinicalTrials.gov